
Who we are
PhiXGen is dedicated to providing top-tier, innovative solutions with an unwavering commitment to quality. The firm's primary mission is to foster the development, deployment, and commercialization of cutting-edge products and services, with a significant focus on producing rifamycin analogues aimed at combating rifampin-resistant Mycobacterium tuberculosis (RR Mtb) strains. In addition, we are advancing research on thermostable enzymes derived from extremophiles for various industrial and environmental applications.
PhiXGen’s work mandate includes offering technical support to beginners encountering challenges in their projects, particularly in Next Generation Sequencing for Genomics, Transcriptomics, and Proteomics studies. We proudly serve a diverse clientele, including national and international government and private sector agencies, industries, universities, colleges, and autonomous bodies. Furthermore, Phixgen provides a range of onsite, offsite, and online training programs for graduates, postgraduates, and corporate professionals, enhancing skill development and fostering innovation across sectors.